Kyverna Therapeutics, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYTX and other ETFs, options, and stocks.About KYTX
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
KYTX Key Statistics
Stock Snapshot
The current Kyverna Therapeutics, Inc.(KYTX) stock price is $5.96, with a market capitalization of 361.78M. The stock trades at a price-to-earnings (P/E) ratio of -1.99.
On 2026-10-20, Kyverna Therapeutics, Inc.(KYTX) stock moved within a range of $5.65 to $5.96. With shares now at $5.96, the stock is trading +5.5% above its intraday low and 0.0% below the session's peak.
Trading volume for Kyverna Therapeutics, Inc.(KYTX) stock has reached 837.29K, versus its average volume of 886.14K.
Over the past 52 weeks, Kyverna Therapeutics, Inc.(KYTX) stock has traded between a high of $13.67 and a low of $5.61.
Over the past 52 weeks, Kyverna Therapeutics, Inc.(KYTX) stock has traded between a high of $13.67 and a low of $5.61.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.